Provided by Tiger Trade Technology Pte. Ltd.

Sanofi SA

43.14
+0.55001.29%
Pre-market: 42.99-0.1500-0.35%04:20 EDT
Volume:2.96M
Turnover:127.15M
Market Cap:103.36B
PE:23.14
High:43.23
Open:42.82
Low:42.82
Close:42.59
52wk High:52.68
52wk Low:40.89
Shares:2.40B
Float Shares:2.16B
Volume Ratio:1.26
T/O Rate:0.14%
Dividend:2.37
Dividend Rate:5.49%
EPS(TTM):1.86
EPS(LYR):3.76
ROE:5.71%
ROA:5.09%
PB:1.30
PE(LYR):11.48

Loading ...

Dow Jones Top Company Headlines at 5 PM ET: Nike Names Pfizer's Denton as Next CFO | FedEx ...

Dow Jones
·
Jun 24

Sanofi Secures European Approval for Multiple Sclerosis Drug, Japan Clearance for Immune Disease Drug

MT Newswires Live
·
Jun 23

Sanofi and Abu Dhabi's Health Department Sign MoU to Explore Vaccine Innovation Centre

MT Newswires Live
·
Jun 23

Dow Jones Top Company Headlines at 3 AM ET: Oracle Sheds 21,000 Jobs | SpaceX, ...

Dow Jones
·
Jun 23

MacroGenics to Receive $24.5 Million in Regulatory Milestone Payment

MT Newswires Live
·
Jun 23

European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading

MT Newswires Live
·
Jun 22

Movement Alert|Sanofi Falls 3.19% in Regular Trading, Phase III Trial Failure of Key Pipeline Drug Continues to Weigh on Shares

Market Focus
·
Jun 22

Sanofi Names New Pharma Research Head as CEO Moves to Speed Up Pipeline -- Update

Dow Jones
·
Jun 22

Movement Alert|Sanofi Falls 3.02% in Pre-Market Trading, Aftershocks From Core Pipeline Drug Phase III Trial Failure Continue

Market Focus
·
Jun 22

Movement Alert|Sanofi Falls 3.11% in Regular Trading, Continued Fallout from Core Pipeline Drug Phase III Trial Failure

Market Focus
·
Jun 18

European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading

MT Newswires Live
·
Jun 17

European Equities Traded in the US as American Depositary Receipts Surge in Monday Trading

MT Newswires Live
·
Jun 15

Sanofi Says US FDA Approved Tzield for Recently Diagnosed Stage 3 Type 1 Diabetes in Children

MT Newswires Live
·
Jun 15

Sanofi's Tzield Receives FDA Approval for Diabetes Treatment

Dow Jones
·
Jun 13

Buy Dianthus on weakness amid ‘overdone’ selloff, says H.C. Wainwright

TIPRANKS
·
Jun 10

Exchange-Traded Funds, Equity Futures Lower Pre-Bell Wednesday Amid Renewed US-Iran Clashes

MT Newswires Live
·
Jun 10

Dianthus sinks after Sanofi halts CIDP Phase 3 study

TIPRANKS
·
Jun 10

Sanofi to halt riliprubart Mobilize phase 3 study

TIPRANKS
·
Jun 10

Sanofi's Development Pipeline Stumbles Again as Rare Disease Drug Trial Halts, Adding Pressure on New CEO

Stock News
·
Jun 10

Sanofi Stops Late-Stage Trial of Autoimmune Disease Therapy After Interim Review

MT Newswires Live
·
Jun 10